MyEClinic
MyEClinic
Health Dictionary Find a Doctor

GemOx-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Overview

GemOx-R regimen refers to a regimen consisting of rituximab, gemcitabine and oxaliplatin used to treat refractory and relapsing mantle cell lymphoma.[1]

Regimen

Regimen

GemGemcitabine

OxOxaliplatin

RRituximab


Indications

Indications

References

References

  1. ↑ 1.0 1.1 Rodríguez J, Gutierrez A, Palacios A, Navarrete M, Blancas I, Alarcón J; et al. (2007). “Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma”. Leuk Lymphoma. 48 (11): 2172–8. doi:10.1080/10428190701618268. PMID 17990179.

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH